comparemela.com

Latest Breaking News On - Boehringer ingelheim animal health in duluth - Page 1 : comparemela.com

Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care

/PRNewswire/ Despite a similar prevalence of the chronic condition, women diagnosed with heart failure have worse outcomes compared to men. A deeper look.

United statesStephan thalenMatt caffreyAlanna morrisEli lillyJennifer forsythAnita holzGlobal business communicationsBoehringer ingelheim pharmaceuticals incEmory university school of medicineBoehringer ingelheimDivision of cardiologyBoehringer ingelheim animal health in duluthClinical developmentCenters for diseaseLilly alliance

Jardiance® phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease

The Independent Data Monitoring Committee recommended that the EMPA-KIDNEY trial be stopped early, following a formal interim assessmentEMPA-KIDNE.

United kingdomStephan thalenRichard haynesColin baigentAnne whitehouseMartin landrayEli lillyWilliam herringtonMohamed eidJeff emmickBoehringer ingelheim pharmaceuticals incClinical development medical affairsOxford population healthBoehringer ingelheimResearch council population health unitPopulation health research unit

Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial

/PRNewswire/ Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance®.

United statesStephan thalenAdriaan voorsMohamed eidJennifer forsythEli lillyJeff emmickGlobal business communicationsBoehringer ingelheim pharmaceuticals incClinical development medical affairsBoehringer ingelheimBoehringer ingelheim animal health in duluthProduct developmentAmerican heart association lateUniversity medical centerDrug administration

Jardiance® provided a significant clinical benefit in adults stabilized in hospital following acute heart failure in EMPULSE phase III trial

/PRNewswire/ Adults hospitalized for acute heart failure were 36% more likely to experience a clinical benefit over 90 days if initiated on Jardiance®.

United statesStephan thalenAdriaan voorsMohamed eidJennifer forsythEli lillyJeff emmickGlobal business communicationsBoehringer ingelheim pharmaceuticals incClinical development medical affairsBoehringer ingelheimBoehringer ingelheim animal health in duluthProduct developmentAmerican heart association lateUniversity medical centerDrug administration

US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction

/PRNewswire/ The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg to reduce the risk of cardiovascular death and.

New yorkUnited statesStephan thalenMohamed eidJaved butlerEli lillyMichele baerJeff emmickGlobal business communicationsBoehringer ingelheim pharmaceuticals incClinical development medical affairsBoehringer ingelheimBoehringer ingelheim animal health in duluthLilly united statesProduct developmentUniversity of mississippi

vimarsana © 2020. All Rights Reserved.